- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02588573
Overall Performance of a 1-day Silicone Hydrogel Lens When Habitual Soft Lens Wearers Are Refit
February 5, 2019 updated by: CooperVision, Inc.
The objective of the study is to compare the overall subjective comfort profile over 8 hours of lens wear in two groups of habitual soft contact lens wearers (daily disposable hydrogel lenses and frequent replacement lenses) when refitted in to somofilcon A lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, single day, randomized, double-masked, non-dispensing, contralateral study.
Participants were recruited into one of two groups - participants who habitually wore etafilcon A: daily disposable hydrogel lenses and participants who habitually wore frequent replacement lenses (FREQ).
Study Type
Interventional
Enrollment (Actual)
103
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Waterloo, Canada
- University of Waterloo
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Center for Contact Lens Research, University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Is at least 17 years of age and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual correction or the assigned study lenses;
- Habitually wears either etafilcon A lens or any frequent replacement contact lenses (as defined in 4.1.1);
- Habitually wear contact lenses with a power between -1.00 and -6.00D (Diopters) (inclusive) in both eyes;
- Demonstrates an acceptable fit with the study lenses;
- Is usually able to wear contact lenses for at least 8 hours per day.
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Is participating in any concurrent clinical or research study;
- Has any known active* ocular disease and/or infection;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- Has known sensitivity to the diagnostic substances (pharmaceuticals), such as fluorescein dye, or products to be used in the study;
- Is aphakic;
- Has undergone refractive error surgery.
Has participated in the previous somfofilcon A study (ORE# 20893)
- For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Etafilcon A (control)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
|
contact lens
contact lens
|
|
Active Comparator: Somofilcon A (test)
Subjects in each of the habitual wearing groups will be randomized to wear either the test or control lens in either the left or right eye.
|
contact lens
contact lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort
Time Frame: 8 hours
|
Subjective ratings for lens comfort of etafilcon A and somofilcon A. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever.
|
8 hours
|
|
Comfort Preference
Time Frame: Baseline and 8 hours
|
Lens preference in regards to comfort of etafilcon A and somofilcon A. Categories: Strongly prefer etafilcon A lens, slightly prefer etafilcon A lens, no preference, slightly prefer somofilcon A lens, strongly prefer somofilcon A lens
|
Baseline and 8 hours
|
|
Bulbar Hyperemia
Time Frame: Baseline and 8 hours
|
Bulbar hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
|
Baseline and 8 hours
|
|
Limbal Hyperemia
Time Frame: Baseline and 8 hours
|
Limbal hyperemia examination using Efron scale 0-4, 0.5 steps, 0=normal, 4=severe.
|
Baseline and 8 hours
|
|
Conjunctival Staining
Time Frame: 8 hours
|
Conjunctival staining was graded in each quadrant with scale 0-4, 0.5 steps, 0=normal, 4=severe of four areas: N - Nasal, T - Temporal, S - Superior, I - Interior, C - Central |
8 hours
|
|
Visual Acuity
Time Frame: Baseline and 8 hours
|
High contrast visual acuity at high illumination was measured with each lens at each visit using a logMAR chart.
|
Baseline and 8 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lyndon Jones, PhD, FCOptom, Centre for Contact Lens Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
October 22, 2015
First Submitted That Met QC Criteria
October 26, 2015
First Posted (Estimate)
October 28, 2015
Study Record Updates
Last Update Posted (Actual)
February 8, 2019
Last Update Submitted That Met QC Criteria
February 5, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-61
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on etafilcon A (control)
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed